US and South Korean microbiome CDMO partnership to build US facility 12-Apr-2022 By Jane Byrne List Bio, together with List Labs, is set to build a new US$125m plant in Indiana, offering end-to-end manufacturing for early-stage development through to commercial production of new microbiome therapeutics.